Postdocs & Students
Ilia Ferrusi
Ilia comes from a background in pharmacology and the pharmaceutical regulatory environment to her graduate studies at McMaster. She received her undergraduate degree in Biology & Pharmacology at McMaster University (2004), where she completed 3 co-op terms spanning academic and industry research environments. Ilia carried out physiology research at the University of Calgary (2002), followed by diagnostics development work at Syn-X Pharma Inc, now Nanogen (2003). Subsequently, she completed her last co-op term with Hoffmann-La Roche Canada Inc in Health Outcomes. Following the completion of her degree, Ilia worked for 2 years in the pharmaceutical pricing and regulatory environment with Palmer D’Angelo Consulting Inc, now part of RTI Health Solutions (2004-2006). Ilia is a CIHR-funded PhD Candidate in her final year of studies.
Program: Health Research Methodology (Health Technology Assessment specialization), Department of Clinical Epidemiology & Biostatistics
Supervisor: Dr. Deborah Marshall
Research interests: health economics, pharmacoeconomics, cost-effectiveness analysis, cost-utility analysis, patient preferences measurement methods, decision-analytic modeling, observational research methods
Recent Awards:
- Award for Excellence in Oral Presentations, McMaster Faculty of Health Sciences Research Plenary. May 18, 2011.
- Best Presentation by a Student, Canadian Association for Population Therapeutics Annual Conference: April 17 – 19, 2011.
- CIHR Frederick Banting and Charles Best Canada Graduate Scholar (Doctoral), 2008-2011
- Ontario Council of Graduate Studies (OCGS) Ontario Women’s Health Scholars Award, 2007-2008
Recent Publications:
- Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic assessment of targeted cancer interventions. Genetics in Medicine, 2011 (in press).
- Ferrusi IL, Leighl NB, Kulin NA, Marshall DA. Economic evaluations of targeted therapy – Do they provide adequate support for decision-makers? Journal of Oncology Practice, 2011; 3S: 36s-45s.
- Ferrusi IL, Marshall DA, Kulin NA, Leighl NB, Phillips KA. Looking Back at 10 Years of Trastuzumab Therapy: What is the Role of HER2 Testing? A Systematic Review of Health Economic Analyses. Personalized Medicine, 2009; 6(2):193-215.
- Ferrusi IL, Ames D, Lim ME, Goeree R. Health Technology Assessment from a Canadian Device Industry Perspective. Journal of the American College of Radiology, 2009; 6(5):353-9.
- Xie F, O’Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, Goeree R. Illustrating economic evaluation of diagnostic technologies: Comparing helicobacter pylori screening strategies in prevention of gastric cancer in Canada. Journal of the American College of Radiology, 2009; 6(5):317-23.
Tel: 905-522-1155 ext. 34917
E-mail: ferrusil@mcmaster.ca